University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
NCT Number: NCT03256773
The purpose of this study is to learn about using the imaging to make images of the lungs and nose with the long-term goal of the research leading to potential treatments and new therapies for patients with cystic fibrosis.
This study is active but is not currently recruiting participants.
14 year and older
All sexes
Observational
Birmingham, Alabama, 35233, United States
Lung Disease is the predominate cause of morbidity and mortality in patients with cystic fibrosis (CF). A better understanding of the primary pathogenesis of CF is essential in order to reveal the features that may lead to the onset of progressive lung disease. Discerning the nature of the CF defect could resolve longstanding controversy and result in a new therapeutic opportunity that may address pathophysiology. Recently the investigators have developed an innovative technology, termed 1-µm resolution optical coherence tomography (µOCT), which enables real-time cross-sectional microscopy of the functional epithelial surface of living airways.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
THE INCLUSION CRITERIA:
THE EXCLUSION CRITERIA:
Time frame: 1 year
to determine if a uOCT probe can image airway epithelial cells from the lung and the nares of adult patients
University of Alabama at Birmingham
Other
Imaging of Human Epithelial Airway Using a High Resolution Micro OCT Catheter (Functional Anatomic Imaging of CF Patients With Early Lung Disease Using Micro OCT)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06512064
Abnormalities, Multiple, Airway Malacia
Indianapolis, Indiana, United States
View Trial DetailsNCT03728595
Altitude Sickness, COPD
Leeds, West Yorkshire, United Kingdom
View Trial DetailsNCT04624490
Asthma, Bronchial Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT07274631
Abnormalities, Multiple, Asthma
Reims, France
View Trial Details